[HTML][HTML] New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease

DL Feldman - Hypertension research, 2010 - nature.com
The renin–angiotensin–aldosterone system (RAAS) has a central function in the regulation
of blood pressure. Aliskiren, the first direct renin inhibitor to be approved for the treatment of …

Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients?: prospective observational study

MV Lehmann, U Zeymer, R Dechend, E Kaiser… - International journal of …, 2013 - Elsevier
Objective Twenty-four hour ambulatory blood pressure (ABP) is superior to office blood
pressure (BP) in predicting cardiovascular events. However, its use to optimise BP control in …

Sustained decrease in blood pressure following missed doses of aliskiren or telmisartan: the ASSERTIVE double-blind, randomized study

R Düsing, P Brunel, IY Baek… - Journal of Hypertension, 2012 - journals.lww.com
Objectives: The AliSkiren Study of profound antihypERtensive efficacy in hyperTensIVE
patients (ASSERTIVE) study was designed to assess the sustained blood pressure (BP) …

Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension

T Lambert, H Blessberger, V Gammer… - Clinical …, 2014 - Wiley Online Library
Background The sympathetic nervous system is an important factor in hypertension. In
patients suffering from resistant hypertension, transfemoral renal sympathetic denervation …

Renale Denervation in der Behandlung der therapieresistenten arteriellen Hypertonie

T Lambert, W Schützenberger… - Wiener Medizinische …, 2014 - Springer
Patients with resistant arterial hypertension have an increased risk of stroke, myocardial
infarction, heart failure, and chronic kidney disease. In many cases, limitations of …